Analyst Activity – Mizuho Raises Its Price Target On Adamas Pharmaceuticals (NASDAQ:ADMS) to $48.00

ME Staff
-
0

Analyst Ratings For Adamas Pharmaceuticals (NASDAQ:ADMS)

Today, Mizuho raised its price target on Adamas Pharmaceuticals (NASDAQ:ADMS) to $48.00 per share.

There are 6 buy ratings on the stock.

The current consensus rating on Adamas Pharmaceuticals (NASDAQ:ADMS) is Buy (Score: 3.00) with a consensus target price of $40.80 per share, a potential 91.55% upside.

Some recent analyst ratings include

  • 9/17/2017-Needham & Company LLC Reiterated Rating of Buy.
  • 9/1/2017-Piper Jaffray Companies Reiterated Rating of Overweight.
  • 8/25/2017-William Blair Reiterated Rating of Ourperform.
  • 8/25/2017-JMP Securities Reiterated Rating of Mkt Outperform .
  • 8/25/2017-Cowen and Company Reiterated Rating of Outperform.
  • 8/9/2017-Noble Financial Reiterated Rating of Buy.

Recent Insider Trading Activity For Adamas Pharmaceuticals (NASDAQ:ADMS)
Adamas Pharmaceuticals (NASDAQ:ADMS) has insider ownership of 29.00% and institutional ownership of 69.24%.

  • On 6/21/2017 Great Point Partners Llc, Major Shareholder, sold 380,000 with an average share price of $17.08 per share and the total transaction amounting to $6,490,400.00. View SEC Filing
  • On 6/21/2017 Jennifer J. Rhodes, Insider, sold 1,041 with an average share price of $17.53 per share and the total transaction amounting to $18,248.73. View SEC Filing
  • On 6/19/2017 Great Point Partners Llc, Major Shareholder, sold 350,000 with an average share price of $17.05 per share and the total transaction amounting to $5,967,500.00. View SEC Filing
  • On 3/21/2017 Gregory T Went, CEO, sold 2,807 with an average share price of $17.03 per share and the total transaction amounting to $47,803.21. View SEC Filing
  • On 3/21/2017 Rajiv Patni, Insider, sold 733 with an average share price of $17.04 per share and the total transaction amounting to $12,490.32. View SEC Filing
  • On 3/21/2017 William J Dawson, CFO, sold 716 with an average share price of $17.02 per share and the total transaction amounting to $12,186.32. View SEC Filing
  • On 9/16/2016 Ix Lp Mdv, Major Shareholder, bought 62,977 with an average share price of $16.48 per share and the total transaction amounting to $1,037,860.96. View SEC Filing

Recent Trading Activity for Adamas Pharmaceuticals (NASDAQ:ADMS)
Shares of Adamas Pharmaceuticals closed the previous trading session at with shares trading hands.